Inhaled environmental particles, pregnancy and neonatal allergy

吸入环境颗粒、妊娠和新生儿过敏

基本信息

  • 批准号:
    7496903
  • 负责人:
  • 金额:
    $ 9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-18 至 2010-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant) Problem and Pilot Data: Environmental exposures during pregnancy can influence the future health of the developing child, but specific mechanisms are unknown. Pilot data show that offspring of mother mice exposed during pregnancy to diesel exhaust particles are more susceptible to allergy than babies of normal mothers. Remarkably, this effect is also caused by control, "inert" titanium dioxide particles. Moreover, '"inert" particles are actually pathogenic/pro-inflammatory in pregnant mice (while causing minimal effects in non pregnant controls). Hence, pregnancy causes a heretofore unrecognized change in lung responses to environmental agents, prompting the central hypothesis: pregnancy-related hormones alter local lung innate immune responses to inhaled environmental particles, leading to systemic cytokine modulation of developing offspring immunity to a state of greater susceptibility to allergy. Specific aim 1: To characterize the local pulmonary and systemic response of pregnant mice to environmental particles, testing the prediction of enhanced pro-Th2 responses in BAL analysis, multiplex cytokine assays of serum and lung gene expression profiling. Specific aim 2: To characterize effects of pregnancy hormones on the alveolar macrophage (AM) response to particles, testing the prediction that progesterone and estrogen promote pro-Th2 AM responses to particles in vitro and in vivo. Specific aim 3: To test the causal role of Th2 cytokines in particle-mediated effects during pregnancy by neutralizing antibody and cytokine treatment strategies. Significance: Rigorous mentorship (aim 1) will prepare the candidate for transition to independence (Aims 2 and 3) and continue developing his research career in environmental disease at a faculty level. This research will provide novel insights into the basic question of early life origins of asthma and the applied question of how environmental agents mediate in utero effects.
描述(由申请人提供) 问题和试点数据:怀孕期间的环境暴露可能会影响发育中儿童的未来健康,但具体机制尚不清楚。试点数据显示,怀孕期间暴露于柴油机尾气颗粒的母鼠的后代比正常母亲的婴儿更容易过敏。值得注意的是,这种效果也是由对照的“惰性”二氧化钛颗粒引起的。 此外,“惰性”颗粒在妊娠小鼠中实际上是致病性/促炎性的(而在非妊娠对照中引起最小的影响)。 因此,妊娠导致了迄今为止尚未认识到的肺对环境因子的反应变化,促使了中心假设:妊娠相关激素改变了局部肺对吸入环境颗粒的先天免疫反应,导致系统性细胞因子调节发育中的后代免疫力,使其对过敏更敏感。 具体目标1:表征妊娠小鼠对环境颗粒物的局部肺和全身反应,测试BAL分析、血清和肺基因表达谱的多重细胞因子测定中增强的pro-Th 2反应的预测。 具体目标2:为了表征妊娠激素对肺泡巨噬细胞(AM)对颗粒物的反应的影响,测试孕酮和雌激素在体外和体内促进Pro-Th 2 AM对颗粒物的反应的预测。 具体目标3:通过中和抗体和细胞因子治疗策略,检测Th 2细胞因子在妊娠期间颗粒介导效应中的因果作用。 重要性:严格的指导(目标1)将准备过渡到独立的候选人(目标2和3),并继续发展他的研究生涯在环境疾病的教师水平。这项研究将提供新的见解的基本问题的早期生命起源的哮喘和应用问题的环境因素如何介导子宫内的影响。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Customized PCR-array analysis informed by gene-chip microarray and biological hypothesis reveals pathways involved in lung inflammatory response to titanium dioxide in pregnancy.
基因 - 芯片微阵列和生物学假设告知的定制PCR阵列分析揭示了妊娠中对肺二氧化钛的肺部炎症反应涉及的途径。
Specific transcriptional enhancement of inducible nitric oxide synthase by targeted promoter demethylation.
  • DOI:
    10.4161/epi.26267
  • 发表时间:
    2013-11
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Gregory DJ;Zhang Y;Kobzik L;Fedulov AV
  • 通讯作者:
    Fedulov AV
Estrogen-mediated impairment of macrophageal uptake of environmental TiO2 particles to explain inflammatory effect of TiO2 on airways during pregnancy.
雌激素介导的巨噬细胞对环境二氧化钛颗粒的摄取受损,解释了怀孕期间二氧化钛对气道的炎症作用。
  • DOI:
    10.3109/1547691x.2014.899411
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Zhang,Yiming;Mikhaylova,Lyudmila;Kobzik,Lester;Fedulov,AlexeyV
  • 通讯作者:
    Fedulov,AlexeyV
Link between epigenomic alterations and genome-wide aberrant transcriptional response to allergen in dendritic cells conveying maternal asthma risk.
  • DOI:
    10.1371/journal.pone.0070387
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Mikhaylova L;Zhang Y;Kobzik L;Fedulov AV
  • 通讯作者:
    Fedulov AV
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXEY V FEDULOV其他文献

ALEXEY V FEDULOV的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXEY V FEDULOV', 18)}}的其他基金

Microbiome in Asthma Induced by Environmental Particle Exposure
环境颗粒暴露诱发哮喘的微生物组
  • 批准号:
    10328480
  • 财政年份:
    2019
  • 资助金额:
    $ 9万
  • 项目类别:
Microbiome in Asthma Induced by Environmental Particle Exposure
环境颗粒暴露诱发哮喘的微生物组
  • 批准号:
    9905519
  • 财政年份:
    2019
  • 资助金额:
    $ 9万
  • 项目类别:
Microbiome in Asthma Induced by Environmental Particle Exposure
环境颗粒暴露诱发哮喘的微生物组
  • 批准号:
    10088448
  • 财政年份:
    2019
  • 资助金额:
    $ 9万
  • 项目类别:
Microbiome in Asthma Induced by Environmental Particle Exposure
环境颗粒暴露诱发哮喘的微生物组
  • 批准号:
    10557119
  • 财政年份:
    2019
  • 资助金额:
    $ 9万
  • 项目类别:
Epigenetic reactivation of human club cell protein 16 in COPD
COPD 中人类俱乐部细胞蛋白 16 的表观遗传再激活
  • 批准号:
    9087235
  • 财政年份:
    2015
  • 资助金额:
    $ 9万
  • 项目类别:
Targeted epigenetic activation of fibroblast genes in pulmonary fibrosis
肺纤维化中成纤维细胞基因的靶向表观遗传激活
  • 批准号:
    8994282
  • 财政年份:
    2015
  • 资助金额:
    $ 9万
  • 项目类别:
Epigenetic reactivation of human club cell protein 16 in COPD
COPD 中人类俱乐部细胞蛋白 16 的表观遗传再激活
  • 批准号:
    8872666
  • 财政年份:
    2015
  • 资助金额:
    $ 9万
  • 项目类别:
Targeted epigenetic activation of fibroblast genes in pulmonary fibrosis
肺纤维化中成纤维细胞基因的靶向表观遗传激活
  • 批准号:
    8823321
  • 财政年份:
    2015
  • 资助金额:
    $ 9万
  • 项目类别:
Inhaled environmental particles, pregnancy and neonatal allergy
吸入环境颗粒、妊娠和新生儿过敏
  • 批准号:
    8272704
  • 财政年份:
    2010
  • 资助金额:
    $ 9万
  • 项目类别:
Inhaled environmental particles, pregnancy and neonatal allergy
吸入环境颗粒、妊娠和新生儿过敏
  • 批准号:
    8068369
  • 财政年份:
    2010
  • 资助金额:
    $ 9万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 9万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 9万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 9万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 9万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 9万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 9万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 9万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 9万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 9万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了